Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for PRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.11M
September 30, 2024 0.436M
June 30, 2024 0.755M
March 31, 2024 1.066M
December 31, 2023 1.369M
September 30, 2023 1.661M
June 30, 2023 1.946M
March 31, 2023 2.225M
Date Value
December 31, 2022 2.495M
September 30, 2022 2.756M
June 30, 2022 3.01M
March 31, 2022 3.259M
December 31, 2021 3.501M
September 30, 2021 3.732M
June 30, 2021 3.959M
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.198M
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.763M
September 30, 2019 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Heron Therapeutics, Inc. 148.15M
Insmed, Inc. 741.01M
Ionis Pharmaceuticals, Inc. 2.189B
Perspective Therapeutics, Inc. 2.866M
Regeneron Pharmaceuticals, Inc. 2.707B